BMP Stimulation Differentially Affects Phosphorylation and Protein Stability of β-Catenin in Breast Cancer Cell Lines

Mustafa Ilhan,Nurcan Hastar,Branka Kampfrath,Deniz Neslihan Spierling,Jerome Jatzlau,Petra Knaus

DOI: https://doi.org/10.3390/ijms25094593

IF: 5.6

2024-04-24

International Journal of Molecular Sciences

Abstract:Increased expression and nuclear translocation of β-CATENIN is frequently observed in breast cancer, and it correlates with poor prognosis. Current treatment strategies targeting β-CATENIN are not as efficient as desired. Therefore, detailed understanding of β-CATENIN regulation is crucial. Bone morphogenetic proteins (BMP) and Wingless/Integrated (WNT) pathway crosstalk is well-studied for many cancer types including colorectal cancer, whereas it is still poorly understood for breast cancer. Analysis of breast cancer patient data revealed that BMP2 and BMP6 were significantly downregulated in tumors. Since mutation frequency in genes enhancing β-CATENIN protein stability is relatively low in breast cancer, we aimed to investigate whether decreased BMP ligand expression could contribute to a high protein level of β-CATENIN in breast cancer cells. We demonstrated that downstream of BMP stimulation, SMAD4 is required to reduce β-CATENIN protein stability through the phosphorylation in MCF7 and T47D cells. Consequently, BMP stimulation reduces β-CATENIN levels and prevents its nuclear translocation and target gene expression in MCF7 cells. Conversely, BMP stimulation has no effect on β-CATENIN phosphorylation or stability in MDA-MB-231 and MDA-MB-468 cells. Likewise, SMAD4 modulation does not alter the response of those cells, indicating that SMAD4 alone is insufficient for BMP-induced β-CATENIN phosphorylation. While our data suggest that considering BMP activity may serve as a prognostic marker for understanding β-CATENIN accumulation risk, further investigation is needed to elucidate the differential responsiveness of breast cancer cell lines.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

The paper attempts to address the issue of how Bone Morphogenetic Protein (BMP) stimulation affects the phosphorylation and protein stability of β-CATENIN in breast cancer cell lines. Specifically, the researchers focus on the following points:

1. **Background Issues**:
- In breast cancer, high expression and nuclear translocation of β-CATENIN are associated with poor prognosis.
- Current therapeutic strategies targeting β-CATENIN are ineffective, necessitating a deeper understanding of its regulatory mechanisms.
- The interaction between BMP and WNT signaling pathways has been extensively studied in many cancer types, but research in breast cancer is limited.

2. **Specific Issues**:
- Analysis of breast cancer patient data reveals that BMP2 and BMP6 are significantly downregulated in tumors.
- Given the low frequency of gene mutations that enhance β-CATENIN protein stability in breast cancer, the researchers hypothesize that reduced expression of BMP ligands may contribute to the high levels of β-CATENIN in breast cancer cells.
- The researchers aim to experimentally verify whether BMP stimulation can reduce β-CATENIN protein stability through a SMAD4-mediated phosphorylation pathway and further explore the differential responses of various breast cancer cell lines to BMP stimulation.

3. **Research Objectives**:
- Investigate how BMP stimulation affects the phosphorylation and protein stability of β-CATENIN in breast cancer cell lines.
- Validate the role of SMAD4 in BMP-induced β-CATENIN degradation.
- Compare the responses of different breast cancer cell lines to BMP stimulation to understand their variability.

Through these studies, the authors hope to provide new insights into the risk of β-CATENIN accumulation in breast cancer and to lay a theoretical foundation for developing more effective therapeutic strategies.